CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
USING ARTIFICIAL INTELLIGENCE IN DIAGNOSIS OF ESOPHAGEAL SQUAMOUS CELL NEOPLASIA: A POST-HOC STUDY OF HIGH-RESOLUTION MICROENDOSCOPY (HRME) IMAGE INTERPRETATION 会议论文
GASTROINTESTINAL ENDOSCOPY, 2019-06-01
作者:  Tan, Mimi C.;  Bhushan, Sheena R.;  Patel, Kalpesh;  Hammad, Tariq;  Khan, Anam
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Olaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancer 会议论文
ANNALS OF ONCOLOGY, 2018-10-01
作者:  Liu, Y-Z.;  Hodgson, D.;  Locker, G.;  Lai, Z.;  Balcerzak, D.
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS) 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Zhou, C.;  Wang, M.;  Cheng, Y.;  Chen, Y.;  Zhao, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Freitas, H. C.;  Park, K.;  Kim, D-W.;  Tiseo, M.;  Hochmair, M. J.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC) 会议论文
ANNALS OF ONCOLOGY, 2018-10-01
作者:  Crino, L.;  Ahn, M-J.;  Han, J-Y.;  Liu, X.;  Ou, S-H. I.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Efficacy And Safety Of Macitentan For Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results From The Randomized Controlled Merit Study 会议论文
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
作者:  Ghofrani, H.;  Simonneau, G.;  D'Armini, A. M.;  Fedullo, P.;  Martin, N.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm plus ) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7) 会议论文
EUROPEAN JOURNAL OF CANCER, 2017-02-01
作者:  Hirsh, V.;  Park, K.;  Tan, E. H.;  Zhang, L.;  O'Byrne, K.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
THE FIRST TRIAL: ANALYSIS OF THE ASIAN SUBGROUP OF TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE 会议论文
HAEMATOLOGICA, 2016-06-01
作者:  Lu, J.;  Lee, J. H.;  Huang, S. Y.;  Qiu, L.;  Lee, J. J.
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04
Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/North Africa: LUX-Head & Neck 3 会议论文
ANNALS OF ONCOLOGY, 2015-12-01
作者:  Tang, P. Z.;  Ahn, M.J.;  Zhang, Q.;  Chan, A.;  Kim, S.B.
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4) 会议论文
ANNALS OF ONCOLOGY, 2015-12-01
作者:  Hu, C. S.;  Chan, A.;  Gao, L.;  Ahn, M.J.;  Cohen, E.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace